M. Hassan-Kadle, M. M. Osman, E. Keleş, H. Eker, K. N. Baydili, Hussein Mahdi Ahmed, A. Osman
{"title":"Clinical Characteristics of Patients with Hepatocellular Carcinoma: A Single-Center 3-Year Experience from Somalia","authors":"M. Hassan-Kadle, M. M. Osman, E. Keleş, H. Eker, K. N. Baydili, Hussein Mahdi Ahmed, A. Osman","doi":"10.1155/2022/3370992","DOIUrl":null,"url":null,"abstract":"Background To evaluate the relationship between prognosticators representing tumor aggressiveness and socio-demographic, laboratory, and imaging findings in patients with hepatocellular carcinoma (HCC). Methods We retrospectively searched patients with HCC between January 2017 and December 2019 in our tertiary referral hospital. The tumor-related factors and liver damage indicators and their relationship to indicate the value of prognosis were analyzed. Results A total of 268 HCC patients, with a male-to-female ratio of 2.8 : 1. The mean age was 52.6 years. The patient with portal vein thrombosis (PVT) was older, had higher liver laboratory parameters (AST, ALT, total bilirubin, and direct bilirubin), and had larger tumor size. Patients with the larger tumor size had a higher AFP level, had more tumor multifocality. The majority of patients were in Child's A (73.6%) and B (17.2%) classes. The laboratory parameters of HCC patients were increased in Child's C compared to other groups of Child-Pugh classification. Conclusions The presence of PVT and large-sized tumor in patients with HCC indicated a poorer prognosis than non-PVT group and small tumor sizes.","PeriodicalId":46297,"journal":{"name":"International Journal of Hepatology","volume":"20 1","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2022-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/3370992","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 2
Abstract
Background To evaluate the relationship between prognosticators representing tumor aggressiveness and socio-demographic, laboratory, and imaging findings in patients with hepatocellular carcinoma (HCC). Methods We retrospectively searched patients with HCC between January 2017 and December 2019 in our tertiary referral hospital. The tumor-related factors and liver damage indicators and their relationship to indicate the value of prognosis were analyzed. Results A total of 268 HCC patients, with a male-to-female ratio of 2.8 : 1. The mean age was 52.6 years. The patient with portal vein thrombosis (PVT) was older, had higher liver laboratory parameters (AST, ALT, total bilirubin, and direct bilirubin), and had larger tumor size. Patients with the larger tumor size had a higher AFP level, had more tumor multifocality. The majority of patients were in Child's A (73.6%) and B (17.2%) classes. The laboratory parameters of HCC patients were increased in Child's C compared to other groups of Child-Pugh classification. Conclusions The presence of PVT and large-sized tumor in patients with HCC indicated a poorer prognosis than non-PVT group and small tumor sizes.
目的:评价肝癌患者肿瘤侵袭性预后指标与社会人口统计学、实验室和影像学表现之间的关系。方法回顾性检索我院三级转诊医院2017年1月至2019年12月HCC患者。分析肿瘤相关因素与肝损害指标及其关系对预后的指示价值。结果共268例HCC患者,男女比例为2.8:1。平均年龄为52.6岁。门静脉血栓(PVT)患者年龄较大,肝脏实验室指标(AST、ALT、总胆红素、直接胆红素)较高,肿瘤大小较大。肿瘤大小越大,AFP水平越高,肿瘤多灶性越明显。以儿童A类(73.6%)和B类(17.2%)为主。Child's C HCC患者的实验室指标较Child- pugh其他组增高。结论肝细胞癌患者存在PVT和大肿瘤,预后较无PVT组和小肿瘤组差。
期刊介绍:
International Journal of Hepatology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the medical, surgical, pathological, biochemical, and physiological aspects of hepatology, as well as the management of disorders affecting the liver, gallbladder, biliary tree, and pancreas.